These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30005984)

  • 1. Preparation and Characterization of Poloxamer 407 Solid Dispersions as an Alternative Strategy to Improve Benznidazole Bioperformance.
    Simonazzi A; Davies C; Cid AG; Gonzo E; Parada L; Bermúdez JM
    J Pharm Sci; 2018 Nov; 107(11):2829-2836. PubMed ID: 30005984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel solid dispersions of benznidazole: preparation, dissolution profile and biological evaluation as alternative antichagasic drug delivery system.
    Fonseca-Berzal C; Palmeiro-Roldán R; Escario JA; Torrado S; Arán VJ; Torrado-Santiago S; Gómez-Barrio A
    Exp Parasitol; 2015 Feb; 149():84-91. PubMed ID: 25583295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced delivery of fixed-dose combination of synergistic antichagasic agents posaconazole-benznidazole based on amorphous solid dispersions.
    Figueirêdo CBM; Nadvorny D; Vieira ACQM; Schver GCRM; Soares Sobrinho JL; Rolim Neto PJ; Lee PI; Soares MFR
    Eur J Pharm Sci; 2018 Jul; 119():208-218. PubMed ID: 29679707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of novel benznidazole formulations: physicochemical characterization and in vivo evaluation on parasitemia reduction in Chagas disease.
    Palmeiro-Roldán R; Fonseca-Berzal C; Gómez-Barrio A; Arán VJ; Escario JA; Torrado-Durán S; Torrado-Santiago S
    Int J Pharm; 2014 Sep; 472(1-2):110-7. PubMed ID: 24928135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of novel formulations for Chagas' disease: Optimization of benznidazole chitosan microparticles based on artificial neural networks.
    Leonardi D; Salomón CJ; Lamas MC; Olivieri AC
    Int J Pharm; 2009 Feb; 367(1-2):140-7. PubMed ID: 18938233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and in vitro evaluation of solid dispersions as strategy to improve albendazole biopharmaceutical behavior.
    Simonazzi A; Cid AG; Paredes AJ; Schofs L; Gonzo EE; Palma SD; Bermúdez JM
    Ther Deliv; 2018 Sep; 9(9):623-638. PubMed ID: 30189808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tailoring microstructural, drug release properties, and antichagasic efficacy of biocompatible oil-in-water benznidazol-loaded nanoemulsions.
    Streck L; Sarmento VHV; de Menezes RPRPB; Fernandes-Pedrosa MF; Martins AMC; da Silva-Júnior AA
    Int J Pharm; 2019 Jan; 555():36-48. PubMed ID: 30448310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unexpected performance of physical mixtures over solid dispersions on the dissolution behavior of benznidazole from tablets.
    Leonardi D; Salomon CJ
    J Pharm Sci; 2013 Mar; 102(3):1016-23. PubMed ID: 23303640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-kinetic release of benznidazole-loaded multiparticulate drug delivery systems based on polymethacrylate interpolyelectrolyte complexes.
    García MC; Martinelli M; Ponce NE; Sanmarco LM; Aoki MP; Manzo RH; Jimenez-Kairuz AF
    Eur J Pharm Sci; 2018 Jul; 120():107-122. PubMed ID: 29705213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benznidazole/Poloxamer 407 Solid Dispersion as a New Strategy to Improve the Treatment of Experimental Trypanosoma cruzi Infection.
    Davies C; Simonazzi A; Micheloud JF; Ragone PG; Cid AG; Negrette OS; Bermúdez JM; Parada LA
    J Parasitol; 2020 Jun; 106(3):323-333. PubMed ID: 32369594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benznidazole in vitro dissolution release from a pH-sensitive drug delivery system using Zif-8 as a carrier.
    de Moura Ferraz LR; Tabosa AÉGA; da Silva Nascimento DDS; Ferreira AS; Silva JYR; Junior SA; Rolim LA; Rolim-Neto PJ
    J Mater Sci Mater Med; 2021 May; 32(6):59. PubMed ID: 33999312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benznidazole Nanoformulates: A Chance to Improve Therapeutics for Chagas Disease.
    Vinuesa T; Herráez R; Oliver L; Elizondo E; Acarregui A; Esquisabel A; Pedraz JL; Ventosa N; Veciana J; Viñas M
    Am J Trop Med Hyg; 2017 Nov; 97(5):1469-1476. PubMed ID: 29016287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technological innovation strategies for the specific treatment of Chagas disease based on Benznidazole.
    Ferraz LRM; Alves AÉG; Nascimento DDSDS; Amariz IAE; Ferreira AS; Costa SPM; Rolim LA; Lima ÁAN; Rolim Neto PJ
    Acta Trop; 2018 Sep; 185():127-132. PubMed ID: 29452113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid dispersion of ursolic acid in Gelucire 50/13: a strategy to enhance drug release and trypanocidal activity.
    de Oliveira Eloy J; Saraiva J; de Albuquerque S; Marchetti JM
    AAPS PharmSciTech; 2012 Dec; 13(4):1436-45. PubMed ID: 23070562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organic solvent-free benznidazole nanosuspension as an approach to a novel pediatric formulation for Chagas disease.
    Magi MS; Lopez-Vidal L; García MC; Stempin CC; Marin C; Maletto B; Palma SD; Real JP; Jimenez-Kairuz AF
    Ther Deliv; 2024; 15(9):699-716. PubMed ID: 39101355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain.
    Cevey ÁC; Mirkin GA; Penas FN; Goren NB
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):12-22. PubMed ID: 26862474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel polymorphs of the anti-Trypanosoma cruzi drug benznidazole.
    Honorato SB; Mendonça JS; Boechat N; Oliveira AC; Mendes Filho J; Ellena J; Ayala AP
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Jan; 118():389-94. PubMed ID: 24076454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of benznidazole:cyclodextrin complexes on the drug bioavailability upon oral administration to rats.
    Leonardi D; Bombardiere ME; Salomon CJ
    Int J Biol Macromol; 2013 Nov; 62():543-8. PubMed ID: 24120966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promising Efficacy of Benznidazole Nanoparticles in Acute Trypanosoma cruzi Murine Model: In-Vitro and In-Vivo Studies.
    Scalise ML; Arrúa EC; Rial MS; Esteva MI; Salomon CJ; Fichera LE
    Am J Trop Med Hyg; 2016 Aug; 95(2):388-93. PubMed ID: 27246447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of benznidazole treatment combined with nifurtimox, posaconazole or AmBisome® in mice infected with Trypanosoma cruzi strains.
    Cencig S; Coltel N; Truyens C; Carlier Y
    Int J Antimicrob Agents; 2012 Dec; 40(6):527-32. PubMed ID: 23063742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.